Sundaram Multi Pap Limited
Sundaram Multi Pap Limited Fundamental Analysis
Sundaram Multi Pap Limited (SUNDARAM.BO) shows weak financial fundamentals with a PE ratio of 63.67, profit margin of 0.87%, and ROE of 1.38%. The company generates $1.3B in annual revenue with weak year-over-year growth of 0.29%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 29.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SUNDARAM.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakSUNDARAM.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateSUNDARAM.BO shows balanced valuation metrics.
Growth Score
WeakSUNDARAM.BO faces weak or negative growth trends.
Financial Health Score
ExcellentSUNDARAM.BO maintains a strong and stable balance sheet.
Profitability Score
WeakSUNDARAM.BO struggles to sustain strong margins.
Key Financial Metrics
Is SUNDARAM.BO Expensive or Cheap?
P/E Ratio
SUNDARAM.BO trades at 63.67 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, SUNDARAM.BO's PEG of 0.45 indicates potential undervaluation.
Price to Book
The market values Sundaram Multi Pap Limited at 1.07 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 9.87 times EBITDA. This is generally considered low.
How Well Does SUNDARAM.BO Make Money?
Net Profit Margin
For every $100 in sales, Sundaram Multi Pap Limited keeps $0.87 as profit after all expenses.
Operating Margin
Core operations generate -0.31 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.38 in profit for every $100 of shareholder equity.
ROA
Sundaram Multi Pap Limited generates $1.15 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Sundaram Multi Pap Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Sundaram Multi Pap Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
SUNDARAM.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
63.67
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.45
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.07
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.55
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.31
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.36
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.01
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How SUNDARAM.BO Stacks Against Its Sector Peers
| Metric | SUNDARAM.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 63.67 | 27.18 | Worse (Expensive) |
| ROE | 1.38% | 860.00% | Weak |
| Net Margin | 0.87% | -121084.00% (disorted) | Weak |
| Debt/Equity | 0.31 | 0.41 | Strong (Low Leverage) |
| Current Ratio | 2.36 | 4.81 | Strong Liquidity |
| ROA | 1.15% | -7173.00% (disorted) | Weak |
SUNDARAM.BO outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Sundaram Multi Pap Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
33.74%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
-93.17%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
127.41%
Industry Style: Cyclical, Commodity, Value
High Growth